Cargando…
Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease
BACKGROUND/AIMS: Though nocturnal acid-breakthrough (NAB) is common in gastroesophageal reflux disease (GERD) patients, its clinical importance results from esophageal acidification, which has been shown to be uncommon. Ilaprazole, a long-acting proton pump inhibitor, may cause NAB infrequently. Acc...
Autores principales: | Karyampudi, Arun, Ghoshal, Uday C, Singh, Rajan, Verma, Abhai, Misra, Asha, Saraswat, Vivek A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383115/ https://www.ncbi.nlm.nih.gov/pubmed/27585842 http://dx.doi.org/10.5056/jnm16087 |
Ejemplares similares
-
Mapping of Brain Activations to Rectal Balloon Distension Stimuli in Male Patients with Irritable Bowel Syndrome Using Functional Magnetic Resonance Imaging
por: Guleria, Anupam, et al.
Publicado: (2017) -
Buccal Buspirone as add–on Therapy to Omeprazole Versus Omeprazole in Treatment of Gastroesophageal Reflux Diseases (GERD)
por: Abdi, Saeed, et al.
Publicado: (2020) -
Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease
por: Famouri, Fatemeh, et al.
Publicado: (2020) -
Slow Transit Constipation Associated With Excess Methane Production and Its Improvement Following Rifaximin Therapy: A Case Report
por: Ghoshal, Uday C, et al.
Publicado: (2011) -
Nocturnal Gastroesophageal Reflux: Assessment and Clinical Implications
por: Lee, Kwang Jae
Publicado: (2011)